Factors Effecting Delayed Time of Thrombolytic Treatment in Patients with Acute ST-Elevated Myocardial Infarction

Abstract

Background: Acute myocardial infarction STEMI is caused by sudden blockage in the blood supply to the heart muscle. The number of patients and death rates are increasing every year. Taking fibrinolytic drugs for a specified period of time increases the chance of survival. The Ministry of Public Health has set indicators for patients to receive fibrinolytic drugs within 30 minutes after the patient arrives at the hospital. In previous studies, a number of patients were still on delayed medication. There are different factors that correlate.

 Objective: Study factors related to delay in fibrinolytic administration in patients with STEMI acute myocardial infarction.

Material and Methods: Retrospective data of STEMI acute myocardial infarction from 1 Oct. 2017 to 30 Sep. 2021. The data collection tools consisted of: personal information record form and record form of attendance factors for patients with acute myocardial infarction Data were analyzed by taking the mean. standard deviation and correlation were determined using Chi-square and independent t-test.

Result: 139 sample were included; it was found that the correlation factors were the duration of the ECG examination. Length of time for doctors to diagnose and prescribe treatment Duration of drug consent of patients and relatives and the length of time the patient arrives at the emergency room until receiving the fibrinolytic drug.

Conclusion: Factors contributing to such delays include the duration of the ECG examination. Length of time for doctors to diagnose and prescribe treatment Duration of drug consent of patients and relatives Which is during the system delay period, improve the process to be able to increase the efficiency of care access to services quickly and reduce the incidence of illness and death.

Keywords: delayed access to services, delayed fibrinolytic therapy, STEMI-type acute myocardial infarction